Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in RECURSION PHARMACEUTICALS IN
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 4M shares of RXRX (RECURSION PHARMACEUTICALS IN), worth $12.4M as of 2026-Q1. The position was decreased (-1.3% shares). RXRX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$12.4M
Current Shares
4M
Total Value Change
-$3.4M
Total Shares Change
+1.9M
Other major holders of RXRX: BNP PARIBAS FINANCIAL MARKETS, BAILLIE GIFFORD & CO, DnB Asset Management AS
Decreased |
| 4M |
-1.3% |
| $12.4M |
| 0.0% |
| $3.54 |
0 |
| 2025-Q4 | Decreased | 4.1M | -2.9% | $16.7M | 0.0% | $4.11 | 0 |
| 2025-Q3 | Decreased | 4.2M | -9.1% | $20.5M | 0.0% | $4.91 | 0 |
| 2025-Q2 | Decreased | 4.6M | -28.0% | $23.4M | 0.0% | $5.03 | 0 |
| 2025-Q1 | Increased | 6.4M | +183.7% | $33.9M | 0.0% | $5.81 | 47 |
| 2024-Q4 | Increased | 2.3M | +5.5% | $15.3M | 0.0% | $6.77 | 30 |
| 2024-Q3 | Increased | 2.1M | +2.0% | $14.1M | 0.0% | $6.98 | 29 |
| 2024-Q2 | Increased | 2.1M | +919.4% | $15.7M | 0.0% | $7.50 | 45 |